Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost

Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost

Myocardial protection against ischemia/reperfusion injury (IRI) is mediated by various ligands, activating different cellular signaling cascades. These include classical cytosolic mediators such as cyclic-GMP (c-GMP), various kinases such as Phosphatydilinositol-3- (PI3K), Protein Kinase B (Akt), Mi...

Full description

Bibliographic Details
Main Authors: Panagiotis Efentakis, Ioanna Andreadou, Konstantinos E. Iliodromitis, Filippos Triposkiadis, Péter Ferdinandy, Rainer Schulz, Efstathios K. Iliodromitis
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:International Journal of Molecular Sciences
Subjects:
cardio-oncology
myocardial infarction
cardioprotection
molecular signaling
anticancer therapies
Online Access:https://www.mdpi.com/1422-0067/23/22/14121

Internet

https://www.mdpi.com/1422-0067/23/22/14121

Similar Items